TTM
7.4%
YoY change
+0.21pp
Trough year (1994)
-1.2%
Peak year (2019)
9.2%
Latest annual
7.6%
EBITDA Margin history chart for Henry Schein (HSIC) from 1994 to 2025
Latest: 7.6%
EBITDA Margin change chart for Henry Schein (HSIC) from 1994 to 2025
Latest: +0.21pp
EBITDA Margin history table for Henry Schein (HSIC) from 1994 to 2025
| 2025 | 7.6% | +0.21pp | ||
| 2024 | 7.4% | +0.32pp | ||
| 2023 | 7.1% | -0.62pp | ||
| 2022 | 7.7% | -0.88pp | ||
| 2021 | 8.6% | +1.43pp | ||
| 2020 | 7.2% | -1.99pp | ||
| 2019 | 9.2% | +3.44pp | ||
| 2018 | 5.7% | -2.85pp | ||
| 2017 | 8.6% | +0.31pp | ||
| 2016 | 8.3% | -0.25pp | ||
| 2015 | 8.5% | -0.02pp | ||
| 2014 | 8.5% | -0.04pp | ||
| 2013 | 8.6% | +0.07pp | ||
| 2012 | 8.5% | +0.12pp | ||
| 2011 | 8.4% | -0.08pp | ||
| 2010 | 8.5% | -0.07pp | ||
| 2009 | 8.5% | +0.58pp | ||
| 2008 | 7.9% | -0.18pp | ||
| 2007 | 8.1% | +0.61pp | ||
| 2006 | 7.5% | +0.35pp | ||
| 2005 | 7.2% | +0.58pp | ||
| 2004 | 6.6% | -1.44pp | ||
| 2003 | 8.0% | +0.05pp | ||
| 2002 | 8.0% | +0.81pp | ||
| 2001 | 7.2% | +0.39pp | ||
| 2000 | 6.8% | +0.32pp | ||
| 1999 | 6.5% | +0.41pp | ||
| 1998 | 6.0% | +0.89pp | ||
| 1997 | 5.2% | -1.55pp | ||
| 1996 | 6.7% | -0.32pp | ||
| 1995 | 7.0% | +8.20pp | ||
| 1994 | -1.2% | — |
- 20257.6%+0.21pp
- 20247.4%+0.32pp
- 20237.1%-0.62pp
- 20227.7%-0.88pp
- 20218.6%+1.43pp
- 20207.2%-1.99pp
- 20199.2%+3.44pp
- 20185.7%-2.85pp
- 20178.6%+0.31pp
- 20168.3%-0.25pp
- 20158.5%-0.02pp
- 20148.5%-0.04pp
- 20138.6%+0.07pp
- 20128.5%+0.12pp
- 20118.4%-0.08pp
- 20108.5%-0.07pp
- 20098.5%+0.58pp
- 20087.9%-0.18pp
- 20078.1%+0.61pp
- 20067.5%+0.35pp
- 20057.2%+0.58pp
- 20046.6%-1.44pp
- 20038.0%+0.05pp
- 20028.0%+0.81pp
- 20017.2%+0.39pp
- 20006.8%+0.32pp
- 19996.5%+0.41pp
- 19986.0%+0.89pp
- 19975.2%-1.55pp
- 19966.7%-0.32pp
- 19957.0%+8.20pp
- 1994-1.2%—
EBITDA Margin values are taken from Henry Schein's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA Margin at Henry Schein (HSIC)
According to Henry Schein's latest reported financial statements, the company's latest reported EBITDA margin is 7.4%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Henry Schein (HSIC) most recent annual EBITDA margin stands at 7.63% (2025) – expanded 0.2 percentage points year-over-year.
Across the available history, EBITDA margin reached its high of 9.17% in 2019 and its low of -1.17% in 1994.
Henry Schein EBITDA Margin by Year
Henry Schein EBITDA Margin 2025: 7.6%
In 2025, Henry Schein reported EBITDA margin of 7.63%, expanded 0.2 percentage points from 2024.
Henry Schein EBITDA Margin 2024: 7.4%
Henry Schein EBITDA margin in 2024 was 7.43%, expanded 0.3 percentage points from 2023.
Henry Schein EBITDA Margin 2023: 7.1%
2023's EBITDA margin for Henry Schein came in at 7.11%, contracted 0.6 percentage points from 2022.
Henry Schein EBITDA Margin 2022: 7.7%
Henry Schein posted EBITDA margin of 7.73% in 2022, contracted 0.9 percentage points from 2021.
Henry Schein EBITDA Margin 2021: 8.6%
Henry Schein EBITDA margin in 2021 was 8.61%.
See more financial history for Henry Schein (HSIC).
Sector peers by EBITDA Margin
Healthcare peers of Henry Schein (HSIC), ranked by their latest EBITDA margin
| 55.4% | |
| 46.6% | |
| 45.9% | |
| 34.6% | |
| 33.9% | |
| 30.3% | |
| 26.9% | |
| 5.1% |
- 55.4%
- 46.6%
- 45.9%
- 34.6%
- 33.9%
- 26.9%
Frequently asked questions
Henry Schein (HSIC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation